{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":28,"n_cols":5,"rows_kept":28,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[14,2,14,3],[15,2,15,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910825571103321"]
[null,null,"Autore",null,"Wilkinson Eric P."]
[null,null,"Titolo",null,"Auditory Brainstem Implants / / Eric P. Wilkinson and Marc S. Schwartz"]
[null,null,"Pubbl/distr/stampa",null,"New York, NY : , : Thieme, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"1-63853-538-8"]
[{"$nulls":4},"1-68420-268-X"]
[{"$nulls":4},"1-62623-827-8"]
[null,null,"Edizione",null,"[First edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (162 pages) : illustrations"]
[null,null,"Disciplina",null,"617.807547"]
[null,null,"Soggetti",null,"Neural stimulation"]
[{"$nulls":4},"Auditory evoked response"]
[{"$nulls":4},"Implants, Artificial"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,"Nota di contenuto",null,"Auditory Brainstem Implants -- Title Page -- Copyright -- Contents -- Preface -- Contributors -- 1 The History and Development of Auditory Brainstem Implants -- 1.1 Early Work in Stimulation of the Brainstem -- 1.2 Auditory Brainstem Response and Advances in Device Manufacturing -- 1.3 Development of Modern Processors and Multi-electrode Arrays -- 1.4 The Penetrating Auditory Brainstem Implant 2 -- 1.5 New Horizons for ABI -- 2 Neuroanatomy and Physiology Relevant to Auditory Brainstem Implants -- 2.1 Introduction -- 2.2 The Cochlea and the Cochlear Nerve -- 2.3 Cochlear Nuclei -- 2.3.1 Two Nuclei in One: The Ventral and Dorsal Cochlear Nucleus -- 2.3.2 Physiology -- 2.4 Human Research -- 2.5 Anatomy and Surgical Approach -- 2.5.1 Extrinsic Anatomy of the Cochlear Nuclei -- 2.6 Intrinsic Anatomy of the Cochlear Nuclei -- 2.7 The Cochlear Nucleus as an Anatomic Interface for Auditory Brainstem Implants -- 2.8 Higher Up in the Auditory Pathway -- 2.8.1 Dorsal Nucleus of Trapezoid Body -- 2.8.2 Inferior Colliculus -- 2.8.3 Medial Geniculate -- 2.8.4 Primary Auditory Cortex -- 2.8.5 Auditory Association Cortex -- 3 Imaging of the Cochlea, Cochlear Nerve, Brainstem, and Auditory System -- 3.1 Introduction -- 3.2 Imaging Anatomy of the Inner Ear and Auditory Pathway -- 3.2.1 Cochlea -- 3.2.2 IAC and the Vestibulocochlear Nerve -- 3.2.3 Cochlear Nucleus -- 3.2.4 Auditory Pathway -- 3.3 Preoperative Imaging of the Auditory Brainstem Implants -- 3.3.1 "]
[{"$nulls":4},"Imaging Techniques -- 3.3.2 Radiological Evaluation of the Auditory Brainstem Implant Candidates -- 3.4 Postoperative Imaging of the Implanted Patient -- 3.4.1 Imaging Issues after ABI -- 4 Clinical Indications for ABI: Patient Selection and Alternatives -- 4.1 Introduction -- 4.2 Clinical Indications -- 4.2.1 Regulatory Status of the Device -- 4.2.2 Current FDA Approval."]
[{"$nulls":4},"4.2.3 Current European CE Mark Approval -- 4.3 Patient Selection in Adults -- 4.3.1 Patient Selection in NF2 -- 4.3.2 Patient Selection in Non-NF2 Indications for ABI -- 4.4 Patient Selection in Children -- 4.4.1 Pediatric Patient Selection for NF2 -- 4.4.2 Cochlear Malformations -- 4.4.3 Cochlear Nerve Aplasia -- 4.4.4 ABI Programming in Pediatric Patients -- 4.4.5 Barriers to Adoption of Expanded ABI Indications -- 4.5 Alternatives to ABI -- 4.5.1 Hearing Preservation -- 4.5.2 Cochlear Implantation -- 5 Surgery for ABI: The Translabyrinthine Approach -- 5.1 Introduction -- 5.2 Anatomic Considerations -- 5.3 Preoperative Evaluation -- 5.4 Operative Technique and Nuances -- 5.4.1 Anesthesia and Positioning -- 5.4.2 Approach and Tumor Resection -- 5.4.3 ABI Placement -- 5.4.4 Closure -- 5.5 Results -- 6 The Retrosigmoid Approach in Auditory Brainstem Implantation -- 6.1 Historical Remarks -- 6.2 The Invention and Evolution of the ABI -- 6.3 Surgical Approaches to the Foramen of Luschka -- 6.4 Surgical Procedure for Retrosigmoid Approach -- 6.4.1 Positioning of the Patient -- 6.4.2 Skin Incision and Trepanation -- 6.4.3 Dura Opening and Tumor Approach -- 6.4.4 Closure after Tumor Resection and ABI Implantation -- 6.4.5 Postoperative Care -- 6.5 Discussion -- 7 Surgery for ABI: Retrolabyrinthine Approach -- 7.1 Introduction -- 7.2 Retrolabyrinthine Surgical Technique -- 7.3 Postoperative Concerns -- 7.4 Discussion -- 7.5 Conclusion -- 8 Auditory Brainstem Implantation in Children: Evaluation and Surgery -- 8.1 Introduction -- 8.2 Indications -- 8.2.1 Definite Indications -- 8.2.2 Probable Indications -- 8.3 CI versus ABI in Children with Hypoplastic Cochlear Nerve -- 8.4 Members of ABI Team -- 8.5 The Age Limit for ABI in Children -- 8.6 Preoperative Evaluation -- 8.6.1 Audiological Assessment Procedure -- 8.7 Surgery -- 8.7.1 Retrosigmoid Approach."]
[{"$nulls":4},"8.7.2 Translabyrinthine Approach -- 8.7.3 Retrolabyrinthine Approach -- 8.8 Intraoperative Monitoring -- 8.9 Initial Stimulation and Follow-Up -- 8.10 Audiological Outcome -- 8.11 Surgical Complications -- 8.12 Conclusion -- 9 Pediatric Auditory Brainstem Implantation: Colletti Team Experience and Special Considerations -- 9.1 Introduction -- 9.2 Total Experience and Selected Patient Study Group -- 9.3 Results -- 9.4 Discussion -- 9.5 Special Situations -- 9.5.1 Nervus Intermedius as a Landmark -- 9.5.2 Use of Near-field Compound Action Potentials -- 9.5.3 Bilateral ABI -- 9.5.4 Resorbable Mesh Cranioplasty and Fat Grafting -- 9.5.5 Revision ABI Surgery -- 10 ABI Engineering and Intraoperative Monitoring: Cochlear -- 10.1 Introduction -- 10.2 ABI Design Engineering -- 10.2.1 Physical Design -- 10.2.2 Electrical Design and Safety -- 10.3 Electrophysiology to Support Optimal Intraoperative Electrode Placement -- 10.3.1 Equipment Setup for EABR -- 10.3.2 Recording Electrode Montage -- 10.3.3 Configuring the EP Machine -- 10.3.4 Configuring the Stimulation -- 10.3.5 Obtaining and Interpreting a Response -- 10.3.6 Intraoperative Response Waveforms -- 10.4 Discussion -- 10.5 Conclusions -- 11 ABI Engineering and Intraoperative Monitoring: MED-EL -- 11.1 Introduction -- 11.2 State-of-the-Art MED-EL ABI System -- 11.3 ABI Indication -- 11.4 Tools in Questionable Candidacy for CI or ABI -- 11.5 Intraoperative eABR Protocol -- 11.6 Benefits of Intraoperative eABR -- 11.7 eABR Morphology -- 11.8 Conclusion -- 12 Programming, Rehabilitation, "]
[{"$nulls":4},"and Outcome Assessment for Adults: I -- 12.1 Outcomes -- 12.1.1 Electrode Number-Evolution of the ABI -- 12.1.2 Tumor Characteristics-Size and History of Radiation -- 12.1.3 Time to Optimal Performance -- 12.1.4 Device Differences -- 12.1.5 Surgical Procedure -- 12.1.6 Patient Selection -- 12.2 Programming and Rehabilitation."]
[{"$nulls":4},"12.2.1 General Plan for Programming -- 12.2.2 Programming Session -- 12.2.3 Nonauditory Side Effects -- 12.2.4 Electrode-Specific Pitch Assessment -- 12.2.5 Long-Term ABI Use, Performance Assessment, and Rehabilitation -- 13 Programming, Rehabilitation, and Outcome Assessment for Adults: II -- 13.1 First Implant Activation -- 13.1.1 Clinical Preparation -- 13.1.2 Setting at Intensive Treatment Unit (ITU) -- 13.2 Implant Programming -- 13.2.1 Activation Procedure -- 13.2.2 First Programming Procedure -- 13.2.3 Second Programming Procedure -- 13.2.4 Standardized Follow-up Program -- 13.2.5 Assessment of Audiological Status -- 13.3 Troubleshooting -- 13.3.1 ABI Activation without any Auditory Sensation -- 13.3.2 ABI Activation with Nonauditory Side Effects 90 -- 13.4 Rehabilitation Program -- 13.4.1 General Training Goals -- 13.4.2 General Auditory Training Strategy -- 13.4.3 Training Materials -- 13.4.4 The Way to Train-Professional Training Support -- 13.4.5 Residential Rehabilitation -- 13.5 Hearing Tests of ABI Function -- 13.5.1 General Considerations for ABI Hearing Tests in NF2 -- 13.5.2 Nonspeech Tests -- 13.5.3 Speech Tests -- 13.6 Long-Term Programming and Adaptation -- 13.6.1 Improvement -- 13.6.2 Deterioration -- 13.6.3 Secondary Failure -- 13.7 Case Presentation -- 13.7.1 Patient History -- 13.7.2 ABI Rehabilitation -- 13.8 Conclusion -- 14 Outcomes in Pediatric ABI: The Hacettepe University Experience -- 14.1 Brief History of ABI Experience in Hacettepe University -- 14.2 Preliminary Results of Pediatric ABI -- 14.3 Long-Term Results of ABI -- 14.3.1 Most Recent Audiological and Language Outcome of 84 Patients with ABI -- 14.4 CI and ABI in Hypoplastic CN -- 14.5 Simultaneous CI and ABI -- 14.6 Bilateral ABI -- 15 Auditory Brainstem Implantation in Tone Language Speakers -- 15.1 Introduction -- 15.2 What is a Tone Language?."]
[{"$nulls":4},"15.3 Speech Assessment Unique to Tone Languages -- 15.3.1 Assessment of Pitch Perception -- 15.3.2 Assessment on Stress Perception -- 15.3.3 Assessment of Segmental Aspects Involving Words -- 15.3.4 Assessment of Speech Production -- 15.4 ABI in NF2 Chinese Speakers -- 15.4.1 Speech and Hearing Outcomes in NF2 Adults -- 15.5 ABI in Non-NF2 Children with Tone Languages -- 15.5.1 Patient Demographics -- 15.5.2 Preoperative Assessment -- 15.5.3 Audiological Perception Outcomes -- 15.5.4 Speech and Language Outcomes of ABI in Tone Language-speaking Children -- 15.6 Case Studies -- 15.6.1 Case 1: KC -- 15.6.2 Case 2: MY -- 15.6.3 Case 3: LC -- 15.7 Interpretation of Speech and Language Outcomes of NF2 Adults -- 15.7.1 Detection of Environmental Sounds -- 15.7.2 Limitations in Speech Recognition without Lipreading -- 15.7.3 Expectation Management in NF2 Patients for ABI Surgery -- 15.8 Interpretation in Prelingually Deafened Cantonese-Speaking Children -- 15.8.1 Prolonged Time Frame of Auditory Development in ABI Children -- 15.8.2 Poor (Slower) Speech Perception and Tone Production Outcomes in Subjects with Relatively Well-developed Environmental Sound Detection -- 15.8.3 Comorbid Nonauditory and Cognitive Conditions -- 15.8.4 Neural Plasticity -- 15.8.5 Etiologies and Outcomes -- 15.8.6 Use of Adjuncts Sign Language and Lipreading -- 15.9 Habilitation of ABI Users in Tone Languages 112 -- 15.10 Conclusion -- 16 Variability in Performance of Auditory Brainstem Implants -- 16.1 Background -- 16.2 Potential Factors Involved in Variability -- 16.2.1 Surgical Factors -- 16.2.2 Patient Factors -- "]
[{"$nulls":4},"16.2.3 Device Factors -- 16.3 Historical and Future Efforts to Develop Novel Strategies -- 17 ABI Program Development -- 17.1 Risk-Benefit Analysis of the Auditory Brainstem Implant -- 17.2 Audiologic Benefit -- 17.2.1 NF2 Patients -- 17.2.2 Adult Non-NF2 Patients."]
[{"$nulls":4},"17.2.3 Pediatric Patients."]
[null,null,null,"Sommario/riassunto","\"Research on the auditory brainstem implant (ABI) has evolved from a highly specialized, narrow field to one involving a wide spectrum of disciplines. Neurotologists, audiologists, otolaryngologists, and neurosurgeons are on the front lines of treatment, while many other specialists play active roles. Auditory Brainstem Implants by renowned ABI experts Eric P. Wilkinson and Marc S. Schwartz is the first dedicated book on ABIs published to date. The state-of-the-art monograph brings together a rich array of materials and resources from an impressive group of pioneering clinicians and researchers from around the world. The text starts with introductory chapters encompassing the history and development of ABIs; relevant neuroanatomy and physiology; imaging of the cochlea, cochlear nerve, brainstem, and auditory system; and clinical indications for ABIs. Surgical chapters detail translabyrinthine, retrosigmoid, and retrolabyrinthine approaches, pediatric applications, auditory midbrain implants, device-specific engineering, and intraoperative monitoring. Auditory testing, performance variables, and results are also reviewed. The final chapters focus on innovative future directions, such as penetrating multisite microelectrodes and the use of optogenetics\"--"]